Valo Stock

HealthTech

Looking to sell Valo stock or options?

Founded: 2018Funding to Date: $406M

Valo, a health tech platform developer, is revolutionizing the drug discovery and development process. By integrating machine learning, cloud computing, and data analysis, Valo's platform examines human data to reveal previously unknown correlations between genetic markers and disease from a human-centric perspective. This innovative approach empowers the healthcare industry to develop drugs for oncology, neurodegenerative, and cardiovascular diseases.

Investors Include:

HBM Healthcare Investments, MissionBlue Capital Partners, Atinum Investment, Public Sector Pension Investment Board, E Squared Capital Management, The Invus Group, HBM Partners, Municipal Employees' Retirement System of Michigan, Flagship Pioneering, InterWest Partners, Lanza techVentures, Longevity Vision Fund, Mercury Fund, Mirae Asset Capital, Koch Disruptive Technologies.

Looking to sell Valo Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you